In continuing to maintain it’s role in helping women injured by dangerous drugs, devices and consumer products the Helpline ” Pink Sites” has launched a Taxotere Helpline and outreach campaign to locate all women effected by permanent hair loss after using Taxotere.
Taxotere Lawyers Filing Hair Loss Lawsuits
In a recent Taxotere lawsuit a woman alleged that her use of breast cancer drug Taxotere (docetaxel) resulted in permanent alopecia, or a total failure of her hair to regrow. Sanofi-Aventis has failed to warn patients that they may not experience hair regrowth after stopping Taxotere.
Taxotere Lawsuits Mount Up
In December of 2015, the U.S. Food and Drug Administration publicly announced numerous adverse incident reports related to Taxotere and permanent alopecia in breast cancer chemotherapy patients.
If these filings continue Taxotere cases may be consolidated in federal multidistrict litigation (MDL)